Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Multiple Myeloma
October 9, 2024
FDA Approves Isatuximab Combination for First-Line Treatment for Newly Diagnosed Multiple Myeloma
Dr. C H Weaver MD
August 28, 2023
Talvey (talquetamab) for Multiple Myeloma
Dr. C H Weaver MD
March 29, 2021
CAR-T Cell Therapy – Advances in The Management of Multiple Myeloma
Dr. C H Weaver MD
February 6, 2021
Overview of Multiple Myeloma
Dr. C H Weaver MD
December 26, 2020
Xpovio – Selinexor Approved by FDA for the Treatment of Multiple Myeloma
Dr. C H Weaver MD
December 9, 2020
Is BCMA The Answer to Treating Multiple Myeloma?
Dr. C H Weaver MD
August 11, 2020
Understanding Stem Cell Transplants for Multiple Myeloma
Dr. C H Weaver MD
June 3, 2020
Sarclisa (isatuximab) – Anti CD38 Targeted Therapy for Myeloma
Dr. C H Weaver MD
July 6, 2018
Thalomid® Approved for Treatment of Newly Diagnosed Multiple Myeloma
Dr. C H Weaver MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
